AKANHealthcare · Drug Manufacturers - Specialty & GenericAKAN Stock Forecast: Akanda Corp. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 10 of 100 as at 31 Oct 2026 — in the weakest quartile.
AKAN stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Akanda Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (97): Smaller than most of the companies we track.
Issuance (1): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
AKAN stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on AKAN, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
AKAN appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
AKAN vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 30 Oct 2026, Akanda Corp. returned −97.1% against +12.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
AKAN analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Akanda Corp. (AKAN) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 0.0×
- Price / sales
- 21.2×
- Price / book
- —
- EV / EBITDA
- −2.2×
Cheaper than 74% of US stocks
Cheaper than 8% of US stocks
Cheaper than 74% of US stocks
- Revenue growth (YoY)
- 79.3%
- Earnings growth (YoY)
- —
- Gross margin
- −2993.6%
- Operating margin
- −1191.5%
- Net margin
- −60.5%
Higher than 91% of US stocks
Higher than 1% of US stocks
Higher than 5% of US stocks
Higher than 9% of US stocks
- Return on equity
- 380.8%
- Return on assets
- −82.1%
- Dividend yield
- 0.0%
Higher than 99% of US stocks
Higher than 4% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
Akanda Corp. (AKAN) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Akanda Corp. has a market value of $14.0M and an enterprise value of $17.4M.
Trailing P/E: 0.0×.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Akanda Corp. employs 46 people.
Data provided by Twelve Data
AKAN vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Akanda Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about AKAN stock
How does Ticker Nerd's model rank AKAN?
As at 31 Oct 2026, Akanda Corp. ranks 10 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (97 of 100).
What is the AKAN stock forecast for 2030?
No analyst covering Akanda Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AKAN are extrapolating price history, which says nothing about the business.
How has AKAN stock performed over the past year?
Akanda Corp. returned -97.1% over the 12 months to 30 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Akanda Corp. do?
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company focused on medical cannabis and wellness products.
About Akanda Corp.
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company focused on medical cannabis and wellness products. Through its subsidiaries, Akanda Corp. develops and supplies medicinal-grade cannabis offerings, including cannabis flower, biomass, concentrates, and cannabis-based medical products for pharmacies, clinics, wholesalers, and other healthcare channels. The company also operates across related business segments that support product distribution and broader infrastructure activities tied to its operating network. Akanda Corp. serves markets in Europe, North America, and other international regions, with activities spanning cultivation, processing, importation, and wholesale distribution. Its role in the financial market reflects exposure to both regulated cannabis operations and adjacent infrastructure services within a small-cap, early-stage business profile.
CEO Mr. Christopher Robert Cooper BBA, M.B.A. · 46 employees · Canada · https://www.akandacorp.com